MabVax Therapeutics Holdings, Inc. filed an amended combined joint plan of liquidation with related disclosure statement in the US Bankruptcy Court on December 16, 2019. As per the amended plan filed, Priority Tax Claims will be paid in full in cash and General Unsecured Claims will be paid through pro rata share of available cash. There is no other change in the payments of claims.